Citius OncologyCTOR
13F holders, Q1 2026 (March 31)14holders −4
1new positions
6sold out
$0.62avg. 13F price*
At the end of Q1 2026, 14 institutions reported holding Citius Oncology Inc. (CTOR) in their 13F filings, down 4 from Q4 2025. 1 opened new positions and 6 sold out. The largest holders were Armistice Capital, LLC ($5.7M), Bank of America Corp. ($2.4M) and Vanguard Capital Management LLC ($332K).
- Company
- Citius Oncology Inc.
- CUSIP
- 17331Y109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1 |
| Exits | 6 | $217K |
All 13F filers, Q4 2025 → Q1 2026: 7,545,057 shares bought and 218,170 shares sold, net +7,326,887 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Armistice Capital, LLC | 0.19% | Add +64.5% | 9,188,855 | $5.7M |
| Bank of America Corp. | 0.00% | Add +1792030.8% | 3,835,160 | $2.4M |
| Vanguard Capital Management LLC | 0.00% | — | 534,824 | $332K |
| Geode Capital Management, LLC | 0.00% | Add +20.3% | 264,733 | $164K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 121,910 | $76K |
| IFP Advisors, Inc | 0.00% | Add +22.9% | 107,424 | $67K |
| BlackRock, Inc. | 0.00% | Add +112.4% | 47,454 | $29K |
| Northern Trust Corp. | 0.00% | No change | 45,746 | $28K |
| State Street Corp. | 0.00% | No change | 42,900 | $27K |
| UBS Group AG | 0.00% | Add +71.6% | 36,840 | $23K |
| Arkadios Wealth Advisors | 0.00% | No change | 11,666 | $7K |
| Osaic Holdings, Inc. | 0.00% | Reduce -11.4% | 10,125 | $6K |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 1 | $1 |
| Royal Bank of Canada | 0.00% | Add +708.7% | 186 | $0 |
"% of holder's portfolio" is CTOR's weight in each manager's 13F, not the share of Citius Oncology Inc. the manager owns.